183623-03-2

183623-03-2 structure

Name: HLF1-11
Chemical Name: Human lactoferrin peptide 1-11
CAS Number: 183623-03-2
Molecular Formula: C₅₆H₉₅N₂₅O₁₄S
Molecular Weight: 1374.6
Catalog: Signaling Pathways Anti-infection Bacterial
Create Date: 2018-06-07 06:48:29
Modify Date: 2026-07-01 21:57:02
HLF1-11, a human lactoferrin-derived peptide, is a broad spectrum antimicrobial agent. HLF1-11 inhibits human MPO activity. HLF1-11 also directs GM-CSF-driven monocyte differentiation toward macrophages, and enhances immune responses[1][2].

Name	Human lactoferrin peptide 1-11

Description	HLF1-11, a human lactoferrin-derived peptide, is a broad spectrum antimicrobial agent. HLF1-11 inhibits human MPO activity. HLF1-11 also directs GM-CSF-driven monocyte differentiation toward macrophages, and enhances immune responses[1][2].
Related Catalog	Research Areas >> Infection Signaling Pathways >> Anti-infection >> Fungal Signaling Pathways >> Anti-infection >> Bacterial
In Vitro	hLF1-11 (1, 10, and 100 μg/mL) directs differentiation of monocytes toward a macrophage subset during granulocyte-macrophage colony-stimulating factor (GM-CSF)-driven monocytes differentiation[2]. hLF1-11 (0.5-250 μg/mL) inhibits human MPO activity[3]. hLF1-11 (100 μg/mL, 90 min) inhibits ROS induction induced by LPS in monocytes[3]. hLF1-11 (8-34 μΜ, 2 h) is active against fluconazole-resistant C. albicans[5].
In Vivo	hLF1-11 (20 mg/kg, injected into the debrided tibial cavity) shows ability against MRSA osteomyelitis in rabbits[4]. hLF1-11 (40 μg/kg, i.v.) is active against C. albicans-infected mice[6]. Animal Model: Rabbits inoculated with CFU MRSA[4] Dosage: 20 mg/kg Administration: Injected into the debrided tibial cavity Result: Reduced bacterial load compared to controls, and reduced the radiological and histopathological score. Animal Model: Neutropenic mice challenged i.v. with C. albicans Dosage: 40 μg/kg Administration: Intravenous injection (i.v) Result: Reduced serum TNFα and IL-6 in infected mice.
References	[1]. Marty Wulferink, et al. The Peptide hLF1-11 as Broad Spectrum Antmicrobial Prophylaxis in HSCT Patients. Blood (2005) 106 (11): 3241. [2]. van der Does AM, et al. Antimicrobial peptide hLF1-11 directs granulocyte-macrophage colony-stimulating factor-driven monocyte differentiation toward macrophages with enhanced recognition and clearance of pathogens. Antimicrob Agents Chemother. 2010 Feb;54(2):811-6. [3]. van der Does AM, et al. The human lactoferrin-derived peptide hLF1-11 exerts immunomodulatory effects by specific inhibition of myeloperoxidase activity. J Immunol. 2012 May 15;188(10):5012-9. [4]. Faber C, et al. Comparable efficacies of the antimicrobial peptide human lactoferrin 1-11 and gentamicin in a chronic methicillin-resistant Staphylococcus aureus osteomyelitis model. Antimicrob Agents Chemother. 2005 Jun;49(6):2438-44. [5]. Lupetti A, et al. Candidacidal activities of human lactoferrin peptides derived from the N terminus. Antimicrob Agents Chemother. 2000 Dec;44(12):3257-63. [6]. upetti A, et al. Human lactoferrin-derived peptide's antifungal activities against disseminated Candida albicans infection. J Infect Dis. 2007 Nov 1;196(9):1416-24.

Molecular Formula	C₅₆H₉₅N₂₅O₁₄S
Molecular Weight	1374.6
Exact Mass	1373.72110398

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

2156970-39-5	220108-56-5
1698671-73-6	1691695-37-0
1506754-77-3	1695097-93-8
1700357-30-7	1693907-75-3
1875293-29-0	1627194-42-6